Batch report — flagship
RETP002
Reta 30mg Pen batch RETP002 was reported by Janoshik Analytical at 99.262% HPLC purity on 4 November 2025. Verify task 86428 with key 97SPA7G1BJUL, then match the returned report to the batch and date. No assay, MS identity, residual or microbial result is published for this record.
For in-vitro laboratory research only. Not for human or veterinary use.
Batch facts
- Format
- Reta 30mg Pen — 300 clicks at 0.1 mg/click
- Batch number
RETP002- Molecule
- Reta (LY-3437943) — CAS 2381089-83-2
- Purity (HPLC)
- 99.262%
- Test method
- HPLC (High-Performance Liquid Chromatography)
- Laboratory
- Janoshik Analytical
- Analysis date
- 4 November 2025
- Task number
86428- Verification key
For the verification method behind this record, read how to verify a Janoshik COA and how to interpret peptide COA and HPLC purity evidence.
Exact format relationship: this batch documents the Reta 30mg Pen. The batch record and its analytical panel are published here; the reusable machine-readable version lives in the public COA evidence dataset.
Janoshik report
The original Janoshik COA for the flagship 30mg pen release. Image and PDF are mirrored from the Janoshik original.
Common questions
What is batch RETP002?
Which format is associated with batch RETP002?
Where is the original Janoshik report?
For the documented 300-click format, use the separate reta pen clicks-to-mg research calculator to connect the listed 0.1 mg-per-click configuration to this batch record. It is a laboratory-planning reference, not administration or dosing guidance.
Continue through the evidence trail
This page documents the flagship 30mg pen batch evidence: what was measured, what was not, and how to confirm it through Janoshik's own verification route. The machine-readable version of the same record sits in the versioned dataset.